New immunomodulatory therapy for cutaneous leishmaniasis

The Syrian conflict has led to a dramatic increase in cases of the parasitic infection cutaneous leishmaniasis. Researchers are developing a novel immunomodulatory analog that may be effective in treating this infection, a study reports.